Gastroesophageal reflux disease in obese patients: The role of obesity in management

Michael L. Kendrick, S. G. Houghton

Research output: Contribution to journalShort surveypeer-review

26 Scopus citations


Gastroesophageal reflux disease (GERD) is common in obese patients. The implications of obesity in the etiology, management and outcomes in treatment for GERD have become increasingly important due to an epidemic of obesity. The increasing prevalence of patients with both obesity and GERD merits evaluation of the appropriate surgical intervention for GERD and its symptoms. With the additional advantages of weight loss and resolution of weight-related morbidity (including GERD) bariatric procedures should be the procedure of choice in patients with medically complicated obesity. Patients in lower obesity classes with body mass indices (BMI) of 30-35kg/m2 without other substantive weight-related comorbidity should prompt consideration of both fundoplication and bariatic procedures, tailoring the best approach based on the specific patient and future implications. Patients classified as overweight but not obese (BMI < 30) are likely best treated with fundoplication; however, no randomized trials comparing fundoplication with the current antireflux bariatic procedures exist.

Original languageEnglish (US)
Pages (from-to)57-63
Number of pages7
JournalDiseases of the Esophagus
Issue number2
StatePublished - Apr 2006


  • Bariatric procedures
  • Fundoplication
  • GERD
  • Gastric bypass
  • Gastroesophageal reflux
  • Obesity

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Gastroesophageal reflux disease in obese patients: The role of obesity in management'. Together they form a unique fingerprint.

Cite this